Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01061502 · ClinicalTrials.gov registry record · Phase 1

Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds

A Phase 1 study, sponsored by Vomaris Innovations.

Completed
Registry status
Phase 1
Development phase
17
Enrollment target

NCT01061502: Completed Phase 1 study, sponsored by Vomaris Innovations.

NCT01061502 is a Phase 1 study that has completed, run by Vomaris Innovations. The registered enrollment target is 17 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01061502, a Phase 1 study, has completed, sponsored by Vomaris Innovations.

COMPLETED
Registry status
Phase 1
Development phase
17 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the use of a bioelectric wound dressing is effective in the healing of skin graft donor site wounds.

Interventions

  • DEVICE Procellera (Bioelectric Wound Dressing)
  • DEVICE Opsite (Transparent Adhesive Dressing)

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2009-09
Est. Completion 2010-11
Phase Phase 1
Vomaris Innovations

4 total trials

What the finished NCT01061502 record still lists

NCT01061502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 2 interventions - of which Procellera (Bioelectric Wound Dressing) is the first listed.

NCT01061502 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01061502 about?

NCT01061502 is a clinical study titled "Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds". The purpose of this study is to determine whether the use of a bioelectric wound dressing is effective in the healing of skin graft donor site wounds.

What is the current status of trial NCT01061502?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2009-09. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01061502?

The interventions under investigation include: Procellera (Bioelectric Wound Dressing) (DEVICE), Opsite (Transparent Adhesive Dressing) (DEVICE).

Who is sponsoring clinical trial NCT01061502?

This trial is sponsored by Vomaris Innovations, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01061502's enrollment target sits among peer trials

17 1785th of 2000 higher than 215 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01061502, the US trial registry maintained by the National Library of Medicine. NCT01061502 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.